🇺🇸 FDA

Company profile · Sponsor

Bolt

Bolt Biotherapeutics

BOLT · NYSE pharma REDWOOD CITY, CA, USA
Pipeline
6
Drugs
0
Patents
7

Quick answer

Bolt (BOLT) is a pharma company. headquartered in REDWOOD CITY, CA, USA. listed on NYSE. NovaPharmaNews links 6 pipeline programs, 0 drugs, and 7 patents to this profile..

Company facts

Ticker BOLT
Exchange NYSE
Company type pharma
Headquarters REDWOOD CITY, CA, USA
SEC CIK 0001641281

Pipeline (6)

Search pipeline →

  1. BDC-1001

    Bolt

    HER2-positive Solid Tumors

    phase 2 small molecule terminated

    1 trial

  2. BDC-1001

    Bolt

    Metastatic Breast Cancer

    phase 2 small molecule terminated

    1 trial

  3. BDC-1001, PERTUZUMAB

    Bolt

    HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 2–POSITIVE METASTATIC BREAST CANCER

    phase 2 small molecule active

    1 trial

  4. BDC-4182

    Bolt

    Gastric Cancer Adenocarcinoma Metastatic

    phase 2 small molecule active

    1 trial

  5. OPDIVO 10 mg/mL concentrate for solution for infusion., BDC-1001, OPDIVO 10 mg/mL concentrate for solution for infusion., OPDIVO 10 mg/mL concentrate for solution for infusion.

    Bolt

    Advanced HER2-Expressing Solid Tumors.

    phase 2 small molecule active

    1 trial

  6. BDC-3042

    Bolt

    Triple Negative Breast Cancer

    phase 1 small molecule terminated

    1 trial

Patents (7)

Search patents →

  1. US 12325750

    Anti-Dectin-2 antibodies and methods of using

    Expires Mon Jun 05 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 11753474

    Anti-Dectin-2 antibodies

    Expires Mon Sep 07 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 11654199

    Thienoazepine immunoconjugates, and uses thereof

    Expires Mon May 18 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 11547761

    Antibody adjuvant conjugates

    Expires Mon Jan 05 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 11400164

    Immunoconjugates targeting HER2

    Expires Mon Jul 28 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 11110178

    Antibody adjuvant conjugates

    Expires Mon Sep 02 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 10675358

    Antibody adjuvant conjugates

    Expires Mon Jun 04 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is Bolt?

Bolt (BOLT) is a pharma company. headquartered in REDWOOD CITY, CA, USA. listed on NYSE. NovaPharmaNews links 6 pipeline programs, 0 drugs, and 7 patents to this profile..

What pipeline programs does Bolt sponsor?

We track 6 ClinicalTrials.gov-linked programs for Bolt, including BDC-1001 and 5 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does Bolt company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.